Pharmacokinetic Analysis and Reporting

AMS methodology is perhaps the most innovative technology to enter the drug development process in several decades.  This advancement has placed unique demands on all supporting components of a pharmacokinetic study and important in this scheme, are innovative approaches to pharmacokinetics analysis that extract insight from the high kinetic resolution and measurement precision afforded by AMS experimentation.  To address this important area,  Vitalea has entered into a strategic alliance with Trials-by-Design, an innovative PK analysis and reporting firm that offers advanced statistical analyses suited for AMS-based studies.  Through our partnership with Trials by Designs, Vitalea can transform your study from concept to completion.